Clinical Trials Logo

Gastric Cancer by AJCC V8 Stage clinical trials

View clinical trials related to Gastric Cancer by AJCC V8 Stage.

Filter by:
  • None
  • Page 1

NCT ID: NCT04736485 Active, not recruiting - Clinical trials for Resectable Carcinoma

Perioperative Treatment in Resectable Gastric Cancer With Spartalizumab (PDR001) in Combination With Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel (FLOT)

GASPAR
Start date: June 28, 2021
Phase: Phase 2
Study type: Interventional

Multicenter, open-label, non randomized, phase 2 trial in resectable gastric or gastroesophageal junction adenocarcinoma: Perioperative Treatment by Spartalizumab (PDR001) in Combination with fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT)